Neogenomics (NEO) Net Margin (2010 - 2026)
Neogenomics (NEO) reported Net Margin of 9.16% for Q1 2026, up 626.0% on a YoY basis from 1.26% in Q1 2025, and down 76.36% quarter-over-quarter from 5.2% in Q4 2025.
Neogenomics (NEO) Net Margin (2010 - 2026) Analysis & Trends
Neogenomics has reported Net Margin for 17 years, with the latest figure at 9.16% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 626.0% year-over-year to 9.16%; the trailing twelve-month figure through Mar 2026 stood at 13.3% (down 176.0% YoY), and the FY2025 full-year result was 14.85%, down 293.0% from the prior year.
- Net Margin for Q1 2026 stood at 9.16%, down from 5.2% in the prior quarter.
- The five-year high for Net Margin was 5.2% in Q4 2025, with the low at 42.17% in Q1 2022.
- Historically, Net Margin has averaged 17.23% across 5 years, with a median of 15.43% in 2025.
- Annual changes were most pronounced in 2022 — Net Margin plunged 9056 bps — and 2023, when it jumped 1973 bps.
- Neogenomics' Net Margin stood at 16.36% in 2022, then jumped by 44 bps to 9.21% in 2023, then gained by 3 bps to 8.91% in 2024, then jumped by 42 bps to 5.2% in 2025, then sank by 76 bps to 9.16% in 2026.
- The last three Net Margin figures came in at 9.16% (Q1 2026), 5.2% (Q4 2025), and 14.45% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -5.68% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 15.06% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 17.29% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 24.41% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 18.47% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -12.22% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 3.40% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 12.28% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 17.89% |
| 10 | Neogenomics | 1.48 Bn | 1.33 Bn | 80.86 Mn | -9.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.16% |
| Dec 31, 2025 | -5.20% |
| Sep 30, 2025 | -14.45% |
| Jun 30, 2025 | -24.87% |
| Mar 31, 2025 | -15.43% |
| Dec 31, 2024 | -8.91% |
| Sep 30, 2024 | -10.55% |
| Jun 30, 2024 | -11.33% |
| Mar 31, 2024 | -17.32% |
| Dec 31, 2023 | -9.21% |
| Sep 30, 2023 | -12.19% |
| Jun 30, 2023 | -16.56% |
| Mar 31, 2023 | -22.44% |
| Dec 31, 2022 | -16.36% |
| Sep 30, 2022 | -28.62% |
| Jun 30, 2022 | -28.23% |
| Mar 31, 2022 | -42.17% |
| Dec 31, 2021 | -33.21% |
| Sep 30, 2021 | -16.77% |
| Jun 30, 2021 | 62.33% |